| Literature DB >> 34395791 |
Noriyuki Otsuki1, Masafumi Sakata1, Yoshio Mori1, Kiyoko Okamoto1, Makoto Takeda1.
Abstract
Rubella is a mildly contagious disease characterized by low-grade fever and a morbilliform rash caused by the rubella virus (RuV). Viruses often use cellular phospholipids for infection. We studied the roles of cellular sphingomyelin in RuV infection. Treatment of cells with sphingomyelinase (SMase) inhibited RuV infection in rabbit kidney-derived RK13 cells and African green monkey (Cercopithecus aethiops) kidney-derived Vero cells. Our data further demonstrated that RuV used cellular sphingomyelin and cholesterol for its binding to cells and membrane fusion at the step of virus entry. Detailed protocols of our assays, which assess the effects of SMase treatment on RuV infectivity in RK13 and Vero cells, are described.Entities:
Keywords: Lipid; Rubella virus; Sphingomyelin; Sphingomyelinase; Virus entry
Year: 2018 PMID: 34395791 PMCID: PMC8328626 DOI: 10.21769/BioProtoc.2992
Source DB: PubMed Journal: Bio Protoc ISSN: 2331-8325